SK12498A3 - Thalidomide analogues from the piperidine-2,6-dione class - Google Patents

Thalidomide analogues from the piperidine-2,6-dione class Download PDF

Info

Publication number
SK12498A3
SK12498A3 SK124-98A SK12498A SK12498A3 SK 12498 A3 SK12498 A3 SK 12498A3 SK 12498 A SK12498 A SK 12498A SK 12498 A3 SK12498 A3 SK 12498A3
Authority
SK
Slovakia
Prior art keywords
substituted
piperidine
dione
hydrogen
formula
Prior art date
Application number
SK124-98A
Other languages
English (en)
Slovak (sk)
Inventor
Oswald Zimmer
Werner Winter
Stephan Wnendt
Kai Zwingenberger
Kurt Eger
Uwe Teubert
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of SK12498A3 publication Critical patent/SK12498A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
SK124-98A 1997-02-01 1998-01-29 Thalidomide analogues from the piperidine-2,6-dione class SK12498A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19703763A DE19703763C1 (de) 1997-02-01 1997-02-01 Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione

Publications (1)

Publication Number Publication Date
SK12498A3 true SK12498A3 (en) 1998-08-05

Family

ID=7819009

Family Applications (1)

Application Number Title Priority Date Filing Date
SK124-98A SK12498A3 (en) 1997-02-01 1998-01-29 Thalidomide analogues from the piperidine-2,6-dione class

Country Status (28)

Country Link
US (1) US6110941A (xx)
EP (1) EP0856513B1 (xx)
JP (1) JPH10316675A (xx)
KR (1) KR19980070959A (xx)
CN (1) CN1109032C (xx)
AR (1) AR010107A1 (xx)
AT (1) ATE311381T1 (xx)
AU (1) AU729733B2 (xx)
BR (1) BR9800253A (xx)
CA (1) CA2228385A1 (xx)
CO (1) CO4940441A1 (xx)
CZ (1) CZ27598A3 (xx)
DE (2) DE19703763C1 (xx)
DK (1) DK0856513T3 (xx)
ES (1) ES2253790T3 (xx)
HK (1) HK1015363A1 (xx)
HU (1) HUP9800146A3 (xx)
IL (1) IL122372A (xx)
NO (1) NO313007B1 (xx)
NZ (1) NZ329325A (xx)
PE (1) PE57499A1 (xx)
PL (1) PL188700B1 (xx)
RU (1) RU2184733C2 (xx)
SI (1) SI0856513T1 (xx)
SK (1) SK12498A3 (xx)
UA (1) UA45408C2 (xx)
UY (1) UY24870A1 (xx)
ZA (1) ZA98749B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10013499A1 (de) * 1998-09-24 2001-09-27 Gruenenthal Gmbh Substituierte Benzamide
DE10002509A1 (de) 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
US7320991B2 (en) 2001-02-27 2008-01-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health Analogs of thalidomide as potential angiogenesis inhibitors
CN100398534C (zh) * 2003-09-15 2008-07-02 天津和美生物技术有限公司 合成酞胺哌啶酮及其衍生物的方法
CA2808646C (en) 2003-09-17 2016-08-23 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Thalidomide analogs as tnf-alpha modulators
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
CA2648216C (en) * 2006-04-13 2016-06-07 Michael Gutschow Tetrahalogenated compounds useful as inhibitors of angiogenesis
WO2012031603A2 (en) 2010-09-09 2012-03-15 Danish Medical Consults Aps Airway administration of angiogenesis inhibitors
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356906A (en) * 1989-10-27 1994-10-18 The Du Pont Merck Pharmaceutical Company (N-phthalimidoalkyl) piperidines useful as treatments for psychosis
WO1992014455A1 (en) * 1991-02-14 1992-09-03 The Rockefeller University METHOD FOR CONTROLLING ABNORMAL CONCENTRATION TNF α IN HUMAN TISSUES
EP0580641B1 (de) * 1991-04-17 1996-12-27 Grünenthal GmbH Neue thalidomidderivate, ein verfahren zu deren herstellung sowie die verwendung derselben in arzneimitteln
US5356406A (en) * 1993-01-08 1994-10-18 Steven Schraga Adaptor to facilitate interconnection of medicine bottle and syringe
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
US5698579A (en) * 1993-07-02 1997-12-16 Celgene Corporation Cyclic amides
EP0925294B3 (en) * 1996-07-24 2018-07-04 Celgene Corporation Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels

Also Published As

Publication number Publication date
AU729733B2 (en) 2001-02-08
AR010107A1 (es) 2000-05-17
ZA98749B (en) 1998-08-03
UY24870A1 (es) 2001-05-31
ES2253790T3 (es) 2006-06-01
CZ27598A3 (cs) 1998-08-12
US6110941A (en) 2000-08-29
HU9800146D0 (en) 1998-03-30
AU5284098A (en) 1998-08-06
NZ329325A (en) 1998-07-28
UA45408C2 (uk) 2002-04-15
HK1015363A1 (en) 1999-10-15
JPH10316675A (ja) 1998-12-02
SI0856513T1 (sl) 2006-02-28
CN1109032C (zh) 2003-05-21
CA2228385A1 (en) 1998-08-01
HUP9800146A2 (hu) 1998-12-28
CN1190096A (zh) 1998-08-12
EP0856513A2 (de) 1998-08-05
HUP9800146A3 (en) 2000-06-28
NO980416D0 (no) 1998-01-30
IL122372A (en) 2002-12-01
RU2184733C2 (ru) 2002-07-10
PE57499A1 (es) 1999-07-10
NO313007B1 (no) 2002-07-29
DE19703763C1 (de) 1998-10-01
NO980416L (no) 1998-08-03
PL324588A1 (en) 1998-08-03
CO4940441A1 (es) 2000-07-24
DE59813233D1 (de) 2006-01-05
BR9800253A (pt) 1999-08-24
PL188700B1 (pl) 2005-03-31
KR19980070959A (ko) 1998-10-26
IL122372A0 (en) 1998-06-15
DK0856513T3 (da) 2005-12-27
EP0856513B1 (de) 2005-11-30
ATE311381T1 (de) 2005-12-15
EP0856513A3 (de) 1998-09-23

Similar Documents

Publication Publication Date Title
RU2163603C2 (ru) Замещенные имидазолидин-2,4-дионовые соединения в качестве фармацевтических действующих веществ
KR880000968B1 (ko) 1, 2-디아미노 시클로부텐-3, 4-디온 및 그의 제조방법
US20040102455A1 (en) Method of inhibiting kinases
MXPA96005023A (en) Substitute compounds of imidazolidin-2,4-dionacomo substances pharmaceutically acti
KR960009570B1 (ko) 이미다졸린 유도체 및 그의 제조방법
IE49496B1 (en) A 1,4-dihydropyridine derivative,its preparation and pharmaceutical compositions containing it
AU689885B2 (en) Lactam derivatives useful for pharmaceutical purposes
SK12498A3 (en) Thalidomide analogues from the piperidine-2,6-dione class
JPH055829B2 (xx)
PT90475B (pt) Processo para a preparacao de pro-farmacos de 2',3'-didehidro-2',3'-didesoxinucleosidos com accao anti-viral
MXPA98000014A (en) Analogue compounds of thalidomide from the class of piperidin-2,6-dio
AU2003205624B2 (en) 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
US6303608B1 (en) 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
RU2814498C2 (ru) Кристаллическая форма ингибитора фосфодиэстеразы, способ ее получения и ее применение
EP3954387A1 (en) Novel compound having pd-l1 expression-suppressing action
JPH01135785A (ja) 4h―キノリジン―4―オン誘導体
JPH01149784A (ja) 4h−キノリジン−4−オン誘導体
CA2168231A1 (en) (thio)carbimidinic acid derivatives and pharmaceutical agents containing them
MXPA98007998A (en) Acrylic prodrogas of n-hydroxymethyl talidomide with immunomodula activity
JPH085884B2 (ja) 5H−ピラゾロ〔4,3−a〕キノリジン−5−オン誘導体
JPH0733660A (ja) 脂質代謝改善剤
JPH01290677A (ja) 5H−ピラゾロ〔4,3−a〕キノリジン−5−オン誘導体